These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 17616534

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association between serum soluble CD30 and serum creatinine before and after renal transplantation.
    López-Hoyos M, San Segundo D, Benito MJ, Fernández-Fresnedo G, Ruiz JC, Rodrigo E, Gómez-Alamillo C, Benito A, Arias M.
    Transplant Proc; 2008 Nov; 40(9):2903-5. PubMed ID: 19010142
    [Abstract] [Full Text] [Related]

  • 6. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
    Azarpira N, Aghdaie MH, Malekpour Z.
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):31-6. PubMed ID: 20061689
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
    Matinlauri I, Höckerstedt K, Isoniemi H.
    Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Soluble CD30 as a prognostic factor for outcome following renal transplantation.
    Platt RE, Wu KS, Poole K, Newstead CG, Clark B.
    J Clin Pathol; 2009 Jul; 62(7):662-3. PubMed ID: 19561239
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Post-transplant increased levels of serum sCD30 is a marker for prediction of kidney allograft loss in a 5-year prospective study.
    Delgado JC, Pavlov IY, Shihab FS.
    Transpl Immunol; 2009 Dec; 22(1-2):1-4. PubMed ID: 19772921
    [Abstract] [Full Text] [Related]

  • 16. CD30, a marker to detect the high-risk kidney transplant recipients.
    Spiridon C, Nikaein A, Lerman M, Hunt J, Dickerman R, Mack M.
    Clin Transplant; 2008 Dec; 22(6):765-9. PubMed ID: 19040559
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation.
    Sengul S, Keven K, Gormez U, Kutlay S, Erturk S, Erbay B.
    Transplantation; 2006 Apr 27; 81(8):1216-9. PubMed ID: 16641611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.